Zenlabs Ethica Ltd Share Price History
Zenlabs Ethica Ltd
BSE : 15 May, 2026
28.8-0.2 (-0.7%)
Prev Close
29.0
Open Price
29.5
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
527
Today's High / Low
29.5 / 27.0
52 WK High / Low
39.2 / 16.5
Market Price of Zenlabs Ethica Ltd
1M
1Y
3Y
5Y
Monitoring Zenlabs Ethica Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter | |
|---|---|
| Sales (Cr.) | 16 |
| Sales YoY Gr. | - |
| Adj EPS | 0.27 |
| YoY Gr. | - |
| Net Profit (Cr.) | 0 |
| BVPS | 7.72 |
Key Financial Parameters
| Parameter | |
|---|---|
| Return on Capital Emp. % | 0 |
| Op. Profit Mgn % | 0 |
| Net Profit Mgn % | 0 |
| Debt to Equity % | 0 |
Latest Shareholding
Promoters Holdings Over Time
About Zenlabs Ethica Ltd
- Zenlabs Ethica Limited was initially incorporated in the name of Neelkanth Technologies Limited on 20 July, 1993.
- With the due approval from the Registrar of Companies, Ministry of Corporate Affairs, name of the Company was changed to Zenlabs Ethica Limited in 2016-17. The Company is one of the top 10 pharmaceutical contract manufacturing companies in India that develops, markets and exports a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti Hypertensive Drugs, Anti-Infective, Soaps & Anti Bacterial Drugs, Nutraceuticals, etc.
- The company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
- It offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India. In 2023, the Company ventured into diversified segments like Neurology and Cytrics.
Popular Search
FAQs for Zenlabs Ethica Ltd Share Price History
What are the key events that typically impact Zenlabs Ethica Ltd's share price history?
Key events that impact Zenlabs Ethica Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Zenlabs Ethica Ltd's share price history?
Stock splits reduce the nominal price of Zenlabs Ethica Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Zenlabs Ethica Ltd?
Dividends can influence Zenlabs Ethica Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Zenlabs Ethica Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Zenlabs Ethica Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Zenlabs Ethica Ltd’s share price history?
To understand Zenlabs Ethica Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
